Authors
Katharina Rahmel-Stein, Jennifer Becker, Berenike Lange, Luise Krajewski, Britta Eiz-Vesper, Ulrich Kalinke
Published in
European journal of immunology. Volume 56. Issue 10.
Abstract
Dendritic cells (DCs) are important targets of human cytomegalovirus (HCMV), yet the factors determining their permissiveness to infection remain incompletely understood. We previously identified a CD1a-/CD86- monocyte-derived DC (moDC) subset with a tolerogenic transcriptional profile and increased susceptibility to HCMV. To test whether tolerogenic programming promotes DC permissiveness, we generated tolerogenic DCs (tolDCs) using vitamin D3 (VitD3), dexamethasone (Dexa), or their combination. TolDCs treated with Dexa alone or with VitD3+Dexa showed a maturation-resistant phenotype, whereas VitD3-treated cells retained partial responsiveness to maturation stimuli. Compared with conventional moDCs, tolDCs were more susceptible to HCMV infection. Functionally, HCMV-exposed tolDCs induced markedly weaker CD4+ and CD8+ T-cell proliferation, with Dexa-treated cells showing the lowest stimulatory capacity. Together, these findings identify tolDCs as a permissive niche for HCMV and suggest that the virus may exploit regulatory DC states to evade immune control.
PMID:
42947569
Bibliographic data and abstract were imported from PubMed on 28 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0